The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy.

Chiesa, Carlo; Sjogreen Gleisner, Katarina; Flux, Glenn; Gear, Jonathan; Walrand, Stephan; Bacher, Klaus; Eberlein, Uta; Visser, Eric P; Chouin, Nicolas; Ljungberg, Michael; Bardiès, Manuel; Lassmann, Michael; Strigari, Lidia; Konijnenberg, Mark W

doi:10.1007/s00259-017-3707-3

The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy.

Chiesa, Carlo

;

Sjogreen Gleisner, Katarina

;

Flux, Glenn

;

Gear, Jonathan

;

Konijnenberg, Mark W

;et.al.

(2017) European Journal of Nuclear Medicine and Molecular Imaging — Vol. 44, n° 11, p. 1783-1786 (2017)

Files

2017_Chiesa_Eur_J_Nucl_Med_Mol_Imaging.pdf

Restricted Access
Adobe PDF
250.3 KB

Request a copy

Details

Authors

Chiesa, Carlo
Author
Sjogreen Gleisner, Katarina
Author
Flux, Glenn
Author
Gear, Jonathan
Author
Walrand, StephanUCLouvain
Author
Konijnenberg, Mark W
Author

Affiliations

Citations

APA
Chicago
FWB

Chiesa, C., Sjogreen Gleisner, K., Flux, G., Gear, J., Walrand, S., Bacher, K., Eberlein, U., Visser, E. P., Chouin, N., Ljungberg, M., Bardiès, M., Lassmann, M., Strigari, L., & Konijnenberg, M. W. (2017). The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. European Journal of Nuclear Medicine and Molecular Imaging, 44(11), 1783-1786. https://doi.org/10.1007/s00259-017-3707-3 (Original work published 2017)